Scientists have developed a novel cancer treatment employing engineered bacteria to transport oncolytic viruses directly into tumors, effectively evading immune detection. This 'Trojan horse' strategy allows viruses to penetrate tumor cells and induce their destruction. Safety mechanisms have been integrated to ensure the virus does not replicate outside the tumor environment, promising a targeted therapeutic approach with reduced systemic toxicity.